Bixiye
Interleukin-13 (IL-13) Antagonist - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2026
Natiijooyinka Raadinta
Soo bandhiga 3861 - 3870 ee natiijooyinka 4226
Bixiye
Cibinqo (abrocitinib) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2026
Bixiye
Cibinqo (abrocitinib) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2026
Bixiye
Tarpeyo - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2025
Bixiye
Ryplazim (plasminogen,human-tvmh) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Tarpeyo - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2025
Bixiye
Oral Anticoagulant - Commercial
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Hepatitis C Direct Acting Antivirals - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2026
Bixiye
Glucose Test Strips and Meters - Medicaid
Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Coverage Exception - NetResults (Key Rx and Focus Rx)
Coverage Exception
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026